BeyondSpring Inc. (BYSI)
Nasdaq: BYSI · Pharmaceutical Preparations · Florham Park, NJ · filing with the SEC since 2016
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 |
| Report filed | Mar 25, 2026 | Mar 27, 2025 | Apr 29, 2024 | Apr 18, 2023 | Apr 14, 2022 | Apr 30, 2021 | Apr 30, 2020 | Apr 30, 2019 | Apr 3, 2018 | Apr 28, 2017 |
| Revenue | 0 | 0 | 0 | 1,351 | 1,351 | 180 | 0 | 0 | 0 | 0 |
| Research and development | 4,388 | 2,644 | 7,272 | 25,582 | 36,888 | 41,793 | 31,342 | 51,618 | 88,928 | 10,437 |
| Selling, general and administrative | 4,557 | 6,110 | 7,809 | 13,008 | 30,703 | 22,598 | 8,965 | 5,927 | 9,053 | 1,931 |
| General and administrative | · | · | · | · | · | · | 8,965 | 5,927 | 9,053 | 1,931 |
| Operating income | -8,945 | -8,754 | -15,081 | -37,239 | -66,240 | -64,211 | -40,307 | -57,545 | -97,981 | -12,368 |
| Interest expense | · | · | · | 17 | 87 | 85 | 206 | · | · | · |
| Interest and investment income | 78 | 59 | 322 | 195 | 98 | 116 | 184 | 211 | 120 | 18 |
| Other income (expense), net | · | · | · | 1,122 | 1,360 | 4 | 0 | 315 | 918 | · |
| Income before income taxes | -8,625 | -8,769 | -13,923 | -36,117 | -64,638 | -63,821 | -40,333 | -57,474 | -96,388 | -12,545 |
| Income tax expense | 90 | 96r | -92 | 163 | 3,570 | 0 | 0 | · | · | · |
| Income from continuing operations | -8,715 | -8,865 | -14,015 | · | · | · | · | · | · | · |
| Income from discontinued operations | -5,502 | -7,828 | -7,933 | · | · | · | · | · | · | · |
| Net income including non-controlling interests | -14,217 | -16,693 | -21,948 | -36,280 | -68,208 | -63,821 | -40,333 | -57,474 | -96,388 | -12,545 |
| Net income to non-controlling interests | · | · | · | -3,001 | -4,029 | -2,848 | -2,248 | -2,605 | -4,625 | -535 |
| Net income | -1,006 | -11,123 | -21,026 | -33,279 | -64,179 | -60,973 | -38,085 | -54,869 | -91,763 | -12,010 |
| Earnings per share, basic | -0.02 | -0.28 | -0.54 | -0.85 | -1.64 | -2.03 | · | · | · | · |
| Earnings per share, basic and diluted | · | · | · | · | -1.64 | -2.03 | -1.55 | -2.42 | -4.40 | -0.75 |
| Weighted average shares, basic | · | · | · | 39,093,246 | 39,023,643 | 29,984,284 | · | · | · | · |
| Weighted average shares, basic and diluted | · | · | · | · | 39,023,643 | 29,984,284 | 24,645,714 | 22,665,265 | 20,866,084 | 16,086,419 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:SalesRevenueNetResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest expense what its borrowing cost
us-gaap:InterestExpenseInterest and investment income what its cash and investments earned
us-gaap:InvestmentIncomeInterestOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitIncome from continuing operations profit from the businesses it keeps
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterestIncome from discontinued operations profit or loss from businesses it sold or closed
us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxNet income including non-controlling interests the whole group's profit, minority holders' share included
us-gaap:ProfitLossNet income to non-controlling interests the share that belongs to minority holders
us-gaap:NetIncomeLossAttributableToNoncontrollingInterestNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, basic and diluted net income per share, where both counts are the same
us-gaap:EarningsPerShareBasicAndDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, basic and diluted the average count, where both counts are the same
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted